We are live on ! Find out more
AP

Arlington Partners Portfolio holdings

AUM $55.4M
1-Year Est. Return 8%
This Fund
S&P 500
This Quarter Est. Return
+5.45%
1 Year Est. Return
+8%
3 Year Est. Return
+43.69%
5 Year Est. Return
+33.63%
10 Year Est. Return
–
AUM
$55.4M
AUM Growth
+$5.26M
Cap. Flow
+$2.9M
Cap. Flow %
5.25%
Top 10 Hldgs %
76.4%
Holding
64
New
2
Increased
29
Reduced
10
Closed
–

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$1.41M
2
AQEC
AQE Core ETF
AQEC
+$777K
3
HONA
Honeywell Aerospace
HONA
+$141K
4
ZTS icon
Zoetis
ZTS
+$127K
5
MDT icon
Medtronic
MDT
+$60.4K

Top Sells

Rank Stock Value
1
GD icon
General Dynamics
GD
+$125K
2
HON icon
Honeywell
HON
+$91K
3
JNJ icon
Johnson & Johnson
JNJ
+$78.8K
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$56.9K
5
WMG icon
Warner Music
WMG
+$44.5K

Sector Composition

Rank Sector Weight
1 Financials 14.32%
2 Healthcare 5.19%
3 Consumer Staples 4.27%
4 Technology 3.98%
5 Communication Services 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VEA icon
1
Vanguard FTSE Developed Markets ETF
VEA
$226B
$21.2M 38.35%
298,007
+20,239
+7% +$1.41M
VGSH icon
2
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$13.1M 23.71%
225,571
– –
PSBD icon
3
Palmer Square Capital BDC
PSBD
$306M
$5.32M 9.6%
510,344
– –
AQEC
4
AQE Core ETF
AQEC
$602M
$768K 1.39%
+32,191
New +$777K
NVO
5
Novo Nordisk
NVO
$223B
$325K 0.59%
6,777
+283
+4% +$12.2K
HD icon
6
Home Depot
HD
$338B
$313K 0.57%
887
+168
+23% +$54.7K
TMO icon
7
Thermo Fisher Scientific
TMO
$198B
$310K 0.56%
618
+114
+23% +$54.7K
ASML icon
8
ASML
ASML
$671B
$306K 0.55%
154
– –
AJG icon
9
Arthur J. Gallagher & Co
AJG
$65.2B
$304K 0.55%
1,324
+200
+18% +$42.5K
AON icon
10
Aon
AON
$78.4B
$294K 0.53%
887
+157
+22% +$50.6K
SOLV icon
11
Solventum
SOLV
$14.1B
$294K 0.53%
3,812
– –
UL icon
12
Unilever
UL
$134B
$291K 0.53%
4,841
+889
+22% +$51.4K
LYV icon
13
Live Nation Entertainment
LYV
$41.9B
$288K 0.52%
1,575
– –
SPGI icon
14
S&P Global
SPGI
$133B
$284K 0.51%
697
+124
+22% +$52.4K
GSK icon
15
GSK
GSK
$104B
$282K 0.51%
5,388
+1,006
+23% +$53.2K
RYAN icon
16
Ryan Specialty Holdings
RYAN
$5.43B
$282K 0.51%
7,470
– –
ROP icon
17
Roper Technologies
ROP
$36.6B
$280K 0.51%
828
+155
+23% +$52.9K
BMY icon
18
Bristol-Myers Squibb
BMY
$124B
$280K 0.51%
4,854
+877
+22% +$50.4K
EL icon
19
Estee Lauder
EL
$29.7B
$279K 0.5%
3,537
– –
ABNB icon
20
Airbnb
ABNB
$86.6B
$279K 0.5%
1,948
+64
+3% +$8.73K
HLN icon
21
Haleon
HLN
$44.5B
$278K 0.5%
29,826
+5,580
+23% +$51.9K
V icon
22
Visa
V
$682B
$277K 0.5%
806
– –
SBUX icon
23
Starbucks
SBUX
$120B
$277K 0.5%
2,706
– –
PG icon
24
Procter & Gamble
PG
$349B
$274K 0.5%
1,870
+211
+13% +$30.7K
CHRW icon
25
C.H. Robinson
CHRW
$24.6B
$271K 0.49%
1,440
+30
+2% +$5.33K
1
2 3

Similar funds

BWA
Bestgate Wealth Advisors Frederick, Maryland $55.4M AUM 15.67% 1-Year Est. Return
JRCM
Jones Road Capital Management New York $55.3M AUM 29.97% 1-Year Est. Return
EI
Ecofi Investissements Nanterre, France $54.9M AUM 10.96% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $54.4M AUM
CAM
Copperwood Asset Management Houston, Texas $54.4M AUM
MML
Mercato Management Legacy Cottonwood Heights, Utah $54.3M AUM
YAVAPFMC
Yahav Achim Ve Achayot - Provident Funds Management Company Tel-Aviv, Israel $53.8M AUM 56.52% 1-Year Est. Return

Arlington Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Arlington Partners held 64 positions worth $55.4M, up 11% from $50.1M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Arlington Partners deployed $2.9M of net new capital in Q2 2026, opening 2 new positions and adding to 29 existing holdings. Its largest new stake was AQE Core ETF: 32,191 shares worth $768K.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was General Dynamics, an estimated $125K trimmed.

  • Arlington Partners's largest Q2 2026 buy was AQE Core ETF: 32,191 shares worth $768K.
  • Arlington Partners added most to Vanguard FTSE Developed Markets ETF in Q2 2026, an estimated $1.41M increase.
  • Arlington Partners's biggest Q2 2026 reduction was General Dynamics, cutting an estimated $125K.
  • Arlington Partners's ten largest holdings make up 76% of its $55.4M portfolio in Q2 2026.
  • Arlington Partners opened 2 new positions and closed 0 in Q2 2026.
  • Arlington Partners's portfolio value rose 11% quarter-over-quarter to $55.4M.

Based on Arlington Partners's 13F filing for Q2 2026, filed 7 Jul 2026.